Sunday, June 1, 2025

Latest

Organigram: Consensus Analyst Estimates For Q2 2021

Organigram Holdings (TSX: OGI) (NASDAQ: OGI) will be reporting their fiscal second quarter on April 13th before the market open. Analysts have a consensus C$4.14 12-month price target on the company, via a total of 14 analysts, with two analysts having strong buy ratings. Two analysts meanwhile have buy ratings, nine have hold ratings and one analyst has a sell rating. The street high comes from Stifel-GMP with a C$6 price target, and the lowest target sits at C$2.

Nine analysts have revenue estimates for the second quarter. The mean between all 9 is C$20.21 million; this number has been revised downwards from C$24.51 million at the start of the year. The highest revenue estimate is C$23.87 million from Alliance Global, while the lowest is C$16 million.

Onto EBITDA estimates, there are currently eight analysts who have second-quarter EBITDA estimates. The mean is currently negative C$5.39 million, with this number having been revised down from almost breakeven at the start of the year. Street high is a negative C$4.1 million EBITDA estimate and the lowest being negative C$6.9 million.

Analysts estimate that quarterly earnings per share will come in at negative C$0.03, with this number being slightly revised down from negative C$0.02 at the start of the year. Street high is negative C$0.01 and the lowest estimate is negative C$0.05 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Alamos Gold Q1 Earnings: The Inside Scoop

Cerrado Gold Q4 Earnings: The Turnaround is Working

B2GOLD Q1 Earnings: Revenue Up, Production & Cash Flow Decline

Recommended

Canadian Copper: The $172M Combined Strategy PEA

ESGold Begins Concentration Tests Ahead Of First Production

Related News

Cognetivity: Echelon Raises Price Target To $1.50 After Biogen Approval

Monday was a very big day for companies who are in the business to help...

Wednesday, June 9, 2021, 11:22:00 AM

ReconAfrica: Haywood Resumes Coverage With $12.50 Price Target

On May 17th, ReconAfrica (CVE: RECO) announced that they closed a C$41.4 million bought deal....

Monday, May 31, 2021, 03:56:00 PM

Tilray: Fourth Quarter Consensus Estimates

Tilray (TSX: TLRY) (NASDAQ: TLRY) will be reporting its fourth quarter financial results on July...

Tuesday, July 27, 2021, 02:22:00 PM

Lundin Mining Sees BMO Maintain Price Target Following Q3 Earnings

Yesterday Lundin Mining (TSX: LUN) reported their third quarter earnings. Third-quarter cash flows were +$272.2...

Thursday, October 29, 2020, 03:29:00 PM

Valens Sees Eight Capital, Haywood, Canaccord Slash Price Targets Following Q2 Financials

Last Wednesday, The Valens Company (TSX: VLNS) released its financial statements for the second quarter...

Monday, July 20, 2020, 11:04:54 AM